October 2011 Issue Table Of Contents

Editor’s Note

• It's About The Customer
• A Month For Raising Awareness

Ask The Board

• Ask The Board October 2011

Outsourcing Insights

• Will A Focus On Innovation Pay Off For Custom Synthesis Providers?
• The Conversation That Got Me Thinking Of A New Business Concept

Bio Data Points

• Single Use Standards: Who’s Setting The Bar?
• The CMO/Client Connection: What Makes It Work?

Feature

• Why The Antibiotic Discovery Business Needs To Be Revamped
• Janet Woodcock — CDER, Safety, And The Cutting Edge
• 5 Areas To Focus On To Achieve Success In Life Sciences

Inside The Industry

• Solid-Dose Pharma Manufacturing Roundtable
• Strong Management Team And IP Protection Trump Science, Survey Reveals
• 5 Key Questions & Answers Regarding Pharmacovigilance
• The New FCPA: What You Need To Know
• Playing To Win: From The Brink Of Bankruptcy And Back
• Baiting Biotech
• How IT Helps Solve Pharma’s R&D Problems

Industry Leader

• A Firsthand Account Of Hiring A CMO
• How CMOs Can Withstand The Test Of Time
• Key CMO Attributes
• Streamlining Site And Patient Management
• C-Path And The Predictive Safety Testing Consortium: Working To Qualify Safety Biomarkers For Preclinical Use
• CMO Selection Criteria
• How To Give Employees Autonomy Without Losing Control
• Don’t Gamble When Selecting A CMO